Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis
Introduction: Refractory ascites is a frequent complication associated with liver cirrhosis. Tolvaptan, a V2-receptor antagonist, has shown effectiveness in improving refractory ascites. This meta-analysis sought to assess the effectiveness of tolvaptan in patients suffering from cirrhosis and refra...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Faculty of Medicine, Universitas Airlangga
2025-01-01
|
| Series: | Current Internal Medicine Research and Practice Surabaya Journal |
| Assuntos: | |
| Acceso en liña: | https://e-journal.unair.ac.id/CIMRJ/article/view/60741 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|